Jubilant Pharmova Limited (NSE:JUBLPHARMA)
India · Delayed Price · Currency is INR 1,024.95
+2.35 (0.23%)
Jul 20, 2026, 3:30 PM IST
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 162.19 billion as of July 20, 2026. Its market cap has decreased by -17.06% in one year.
Market Cap
162.19B
Enterprise Value
185.69B
Revenue
82.80B
Ranking
n/a
PE Ratio
40.70
Stock Price
1,024.95
ChartMarket Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 162.19B, an increase of 39,776.57%. That is a compound annual growth rate of 25.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 162.19B | -4.73% |
| Dec 31, 2025 | 170.24B | -2.67% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 338.08B |
| Wockhardt | 308.85B |
| Piramal Pharma | 238.12B |
| Eris Lifesciences | 201.67B |
| NATCO Pharma | 169.26B |
| Cohance Lifesciences | 169.06B |
| Alembic Pharmaceuticals | 162.18B |
| Alivus Life Sciences | 139.10B |